Detailed answers about CALYX NEUROLOGICAL SERVICES (CNS) LIMITED, including incorporation, status, business activity, and accounts information.
When was CALYX NEUROLOGICAL SERVICES (CNS) LIMITED founded?
CALYX NEUROLOGICAL SERVICES (CNS) LIMITED was officially incorporated on 15 November 2018 and is registered under company number 11679289. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CALYX NEUROLOGICAL SERVICES (CNS) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CALYX NEUROLOGICAL SERVICES (CNS) LIMITED?
CALYX NEUROLOGICAL SERVICES (CNS) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CALYX NEUROLOGICAL SERVICES (CNS) LIMITED do?
CALYX NEUROLOGICAL SERVICES (CNS) LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is CALYX NEUROLOGICAL SERVICES (CNS) LIMITED's registered address?
The registered office address of CALYX NEUROLOGICAL SERVICES (CNS) LIMITED is BANKSIDE 300 PEACHMAN WAY, BROADLAND BUSINESS PARK, NORWICH, NORFOLK, UNITED KINGDOM, NR7 0LB. This is the official address filed with Companies House for legal and statutory correspondence.
Is CALYX NEUROLOGICAL SERVICES (CNS) LIMITED financially stable?
The most recent accounts for CALYX NEUROLOGICAL SERVICES (CNS) LIMITED were made up to 30 November 2024, filed as MICRO ENTITY. Next accounts are due by 31 August 2026.